SG Medical Ltd - Period Ending 2021-03-31

SG Medical Ltd - Period Ending 2021-03-31


SG Medical Ltd 11913592 false 2020-04-01 2021-03-31 2021-03-31 The principal activity of the company is Medical Consultancy Digita Accounts Production Advanced 6.29.9459.0 true 11913592 2020-04-01 2021-03-31 11913592 2021-03-31 11913592 bus:OrdinaryShareClass1 2021-03-31 11913592 core:RetainedEarningsAccumulatedLosses 2021-03-31 11913592 core:ShareCapital 2021-03-31 11913592 core:CurrentFinancialInstruments core:WithinOneYear 2021-03-31 11913592 bus:SmallEntities 2020-04-01 2021-03-31 11913592 bus:AuditExemptWithAccountantsReport 2020-04-01 2021-03-31 11913592 bus:FullAccounts 2020-04-01 2021-03-31 11913592 bus:SmallCompaniesRegimeForAccounts 2020-04-01 2021-03-31 11913592 bus:RegisteredOffice 2020-04-01 2021-03-31 11913592 bus:Director1 2020-04-01 2021-03-31 11913592 bus:OrdinaryShareClass1 2020-04-01 2021-03-31 11913592 bus:PrivateLimitedCompanyLtd 2020-04-01 2021-03-31 11913592 countries:England 2020-04-01 2021-03-31 11913592 2019-03-29 2020-03-31 11913592 2020-03-31 11913592 bus:OrdinaryShareClass1 2020-03-31 11913592 core:RetainedEarningsAccumulatedLosses 2020-03-31 11913592 core:ShareCapital 2020-03-31 11913592 core:CurrentFinancialInstruments core:WithinOneYear 2020-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 11913592

SG Medical Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2021

 

SG Medical Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 4

 

SG Medical Ltd

Company Information

Director

J Syme-Grant

Registered office

Oakmoore Court
11c Kingswood Road
Hampton Lovett
Droitwich
Worcestershire
WR9 0QH

Accountants

Ballards LLP
Chartered Accountants
Oakmoore Court
11c Kingswood Road
Hampton Lovett
Droitwich
Worcestershire
WR9 0QH

 

SG Medical Ltd

(Registration number: 11913592)
Balance Sheet as at 31 March 2021

Note

2021
£

2020
£

Current assets

 

Cash at bank and in hand

 

13,640

13,056

Creditors: Amounts falling due within one year

4

(4,820)

(5,593)

Net assets

 

8,820

7,463

Capital and reserves

 

Called up share capital

5

100

100

Profit and loss account

8,720

7,363

Shareholders' funds

 

8,820

7,463

For the financial year ending 31 March 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 1 November 2021
 

.........................................
J Syme-Grant
Director

   
 

SG Medical Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2021

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Oakmoore Court
11c Kingswood Road
Hampton Lovett
Droitwich
Worcestershire
WR9 0QH

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

SG Medical Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2021

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2020 - 1).

4

Creditors

Creditors: amounts falling due within one year

Note

2021
£

2020
£

Due within one year

 

Amounts owed to related parties

2,950

2,265

Other creditors

 

1,870

3,328

 

4,820

5,593

5

Share capital

Allotted, called up and fully paid shares

 

2021

2020

 

No.

£

No.

£

Ordinary Shares of £1 each

100

100

100

100

         

On 29 March 2019 100 ordinary shares of £1 each were issued on incorporation of the company for an agregate consideration of £100.